NanoVibronix (NASDAQ:NAOV) Stock Crosses Below 50-Day Moving Average of $0.87

Shares of NanoVibronix, Inc. (NASDAQ:NAOV) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $0.87 and traded as low as $0.68. NanoVibronix shares last traded at $0.69, with a volume of 726,512 shares traded.

NanoVibronix Trading Down 6.1 %

The stock’s 50-day moving average price is $0.87 and its 200-day moving average price is $0.98.

NanoVibronix (NASDAQ:NAOV) last released its quarterly earnings data on Monday, April 8th. The company reported ($0.39) earnings per share (EPS) for the quarter. The company had revenue of $1.18 million for the quarter. NanoVibronix had a negative return on equity of 123.23% and a negative net margin of 162.55%.

Hedge Funds Weigh In On NanoVibronix

An institutional investor recently bought a new position in NanoVibronix stock. Armistice Capital LLC acquired a new position in shares of NanoVibronix, Inc. (NASDAQ:NAOV) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 29,023 shares of the company’s stock, valued at approximately $57,000. Armistice Capital LLC owned approximately 1.75% of NanoVibronix at the end of the most recent reporting period. 16.39% of the stock is currently owned by hedge funds and other institutional investors.

NanoVibronix Company Profile

NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.